EVH

Evolent Health Inc

EVH, USA

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

https://www.evolent.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
EVH
stock
EVH

Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership Yahoo Finance UK

Read more →
EVH
stock
EVH

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating 富途牛牛

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$11.0357

Analyst Picks

Strong Buy

9

Buy

4

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.56

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-2.48 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.85 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

1.43 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.91

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 107.93% of the total shares of Evolent Health Inc

1.

Vanguard Group Inc

(9.4175%)

since

2025/06/30

2.

Cadian Capital Management LP

(8.989%)

since

2025/06/30

3.

BlackRock Inc

(8.0853%)

since

2025/06/30

4.

Morgan Stanley - Brokerage Accounts

(6.9436%)

since

2025/06/30

5.

Durable Capital Partners LP

(5.5387%)

since

2025/06/30

6.

FMR Inc

(5.5362%)

since

2025/06/30

7.

Engaged Capital LLC

(5.0482%)

since

2025/06/30

8.

William Blair Investment Management, LLC

(3.7293%)

since

2025/06/30

9.

Eventide Asset Management, LLC

(3.524%)

since

2025/06/30

10.

Fidelity Small Cap Value Fund

(3.3578%)

since

2025/06/30

11.

Vanguard Total Stock Mkt Idx Inv

(3.0096%)

since

2025/07/31

12.

Goldman Sachs Group Inc

(2.6751%)

since

2025/06/30

13.

JPMorgan Chase & Co

(2.6684%)

since

2025/06/30

14.

State Street Corp

(2.5635%)

since

2025/06/30

15.

iShares Russell 2000 ETF

(2.4501%)

since

2025/08/31

16.

Rock Springs Capital Management LP

(2.4322%)

since

2025/06/30

17.

UBS Group AG

(2.4245%)

since

2025/06/30

18.

Dimensional Fund Advisors, Inc.

(2.3922%)

since

2025/06/30

19.

Vanguard Small Cap Index

(2.3312%)

since

2025/07/31

20.

Geode Capital Management, LLC

(2.3003%)

since

2025/06/30

21.

D. E. Shaw & Co LP

(1.8146%)

since

2025/06/30

22.

Eventide Healthcare & Life Sciences I

(1.7856%)

since

2025/06/30

23.

Eventide Gilead N

(1.7073%)

since

2025/06/30

25.

Silvercrest Asset Management Group LLC

(1.5356%)

since

2025/06/30

26.

Vanguard Small Cap Growth Index Inv

(1.3216%)

since

2025/07/31

27.

JPMorgan Small Cap Growth A

(1.2888%)

since

2025/07/31

28.

Maverick Capital Ltd

(1.2008%)

since

2025/06/30

29.

Fidelity Select Medical Tech and Devcs

(1.1575%)

since

2025/07/31

30.

Fidelity Select Health Care

(1.0382%)

since

2025/07/31

31.

Fidelity Small Cap Index

(1.0165%)

since

2025/06/30

32.

Vanguard Institutional Extnd Mkt Idx Tr

(1.001%)

since

2025/07/31

33.

William Blair SMID Growth CIT 5

(0.9656%)

since

2025/07/31

34.

William Blair SMID Growth CIT 1

(0.9656%)

since

2025/07/31

35.

Glenmede Small Cap Equity

(0.8474%)

since

2025/06/30

36.

Glenmede Small Cap Equity Adv

(0.8474%)

since

2025/06/30

37.

Fidelity Advisor Health Care I

(0.6177%)

since

2025/07/31

38.

iShares Russell 2000 Value ETF

(0.6003%)

since

2025/08/31

39.

Multi-Manager Small Cap Eq Strat Inst

(0.5787%)

since

2025/07/31

40.

William Blair Small-Mid Cap Growth I

(0.5628%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.1239

Latest Release

Date

2025-09-30

EPS Actual

0.05

EPS Estimate

0.11

EPS Difference

-0.06

Surprise Percent

-54.5455%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(5.5)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(3.5)
Value
Fair Value(4.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.